Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo

Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood

First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma

Immunotherapy in multiple myeloma–possibility or probability?

Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma